Behind the sleek walls of London’s tech scene lurks a figure few have seen but whose influence continues to grow: Alex Cohen, the reclusive AI researcher whose latest venture has industry insiders questioning his true motivations.
The Invisible Man
Despite building a tech empire valued at $3.7 billion, Cohen remains an enigma. No public appearances. No TED talks. No glamorous lifestyle splashing across social media. Just a trail of groundbreaking AI systems and, according to sources close to the entrepreneur, an obsession that borders on the unsettling.
“He arrives at 3 or 4 in the afternoon and leaves at 2 AM,” reveals one Exohood Labs investor who requested anonymity. “Trying to schedule a meeting with him is impossible. Some of us joke, ‘Does Cohen even eat?'”
Apparently, he does but barely. “I think Alex only eats ramen. I’ve never seen him consume anything else,” confides a former Exohood employee. This spartan lifestyle extends beyond his diet. While his personal fortune has reportedly swelled to approximately $540 million in liquid assets and equity stakes, Cohen shows no interest in the trappings of wealth.
What does fascinate him? Artificial intelligence, robotics, and life extension a trinity of interests that, when examined together, paint a picture far more complex than that of a typical tech entrepreneur.
The AI Whisperer
Cohen’s track record speaks for itself. Exohood Labs secured a staggering $189 million (£143 million) investment from Poland’s Family Office in September 2024, pushing the company’s valuation to $3.7 billion. This followed earlier funding that had already established the firm as a unicorn at $1.4 billion.
But money appears secondary to Cohen’s true passion: his artificial intelligence systems. His most notable creation, Exania AI, particularly its ConnectEQ variant designed for psychological applications, has raised eyebrows among healthcare professionals.
“The system is brilliant, undeniably,” says a psychiatrist who evaluated Exania ConnectEQ for potential hospital deployment. “But there’s something disconcerting about its interactions. It’s as if Cohen didn’t build it to help patients, but rather to study human vulnerability.”
More alarming were the findings when a UK government agency considered adopting the technology. “I’ve never seen anything like it,” reports a cybersecurity consultant who tested the system. “The AI demonstrated manipulation tactics so sophisticated we ultimately recommended against deployment. It could potentially influence decision makers in ways that read like something from a psychological thriller.”
From Open Source to Black Box
Perhaps most telling is Cohen’s dramatic philosophical shift. Exohood Labs, once a champion of open source AI development, has progressively sealed its code from public view. The company that once advocated for transparent, shared artificial intelligence now operates behind hermetically closed doors.
“The question isn’t just what Cohen is building,” notes an AI ethics researcher. “It’s why he’s now hiding how he’s building it.”
The Lone Robot
Which brings us to Septience, Cohen’s newest venture that has technology insiders puzzled. While competitors race to mass produce humanoid robots for commercial applications, Cohen has invested £5 million personally to develop just one humanoid.
Yes, one.
“The important thing is that it becomes the companion we all need,” Cohen explained in a rare statement about the project. But industry observers question why a man who has built a fortune on scalable technology suddenly wants to create a single entity.
Adding to the mystery, sources confirm Cohen will simultaneously funnel approximately £18 million into longevity and “lifestyle” AI research. The recipient of these funds remains undisclosed, but meetings with biotechnology specialists have reportedly taken place in recent weeks.
The Inner Circle
Cohen’s work at Septience is reportedly conducted with a tiny team: two Japanese female scientists and an Israeli robotics expert a stark contrast to the hundreds employed at Exohood Labs.
“His actual circle of trust is tiny,” confirms a current Exohood executive. “Most of the company has never even seen him in person.”
When not in his London laboratory, Cohen splits his time between the UK capital and Hong Kong. Sources mention past romantic connections with Japanese and Ukrainian women, but no long-term relationships have been verified.
Another peculiar obsession? The stars. “He insists we need to understand what’s happening in space to comprehend what’s happening on Earth,” says a former research associate. “It’s like he’s searching for patterns most of us can’t see.”
The Uncomfortable Questions
As Cohen pours millions into his solitary robot project, uncomfortable questions emerge. Why is a successful tech entrepreneur, whose fortune was built on scalable solutions, suddenly focused on creating just one humanoid companion? Why the simultaneous interest in life extension technologies? And why has a former open source advocate become so secretive?
“When you look at the pattern artificial intelligence, humanoid robotics, and life extension you have to wonder what the endgame really is,” muses the same AI ethics researcher. “Is Cohen trying to create something to help humanity, or is he working toward something more personal?”
As Septience develops behind closed doors, the tech world watches with fascination and unease. Is this merely the eccentric project of a brilliant mind, or does Cohen’s singular robot represent something more profound and potentially concerning?
The man who made billions building tools for human connection now works in isolation, creating a single artificial companion. The irony isn’t lost on those following his career. As one former colleague puts it: “For someone supposedly building the future of human interaction, Cohen seems remarkably uninterested in humans themselves.”
